Cassava Sciences (PTIE) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-12.33M
Non-cash stock based compensation	3.49M
Depreciation and amortization	41K
Non-cash net interest income	-3K
Program fee revenue
Receivables
Other current assets	-18K
Other assets
Accounts payable	49K
Accrued development expense	-150K
Other accrued liabilities
Accrued compensation and benefits	-283K
Net cash provided by (used in) operating activities
Purchases of marketable securities	-2.05M
Maturities of marketable securities	1.5M
Net cash provided by investing activities
Proceeds from exercise of common stock options
Net cash provided by financing activities
Net increase in cash and cash equivalents	-10.09M
Cash and cash equivalents at beginning of the period	31.3M
Cash and cash equivalents at end of the period	21.21M

Entities mentioned with PTIE

View All Entities